Spruce Biosciences (SPRB)
NASDAQ:SPRB
US Market
Holding SPRB?
Track your performance easily

Spruce Biosciences (SPRB) Financial Statements

283 Followers

Spruce Biosciences Financial Overview

Spruce Biosciences's market cap is currently ―. The company's EPS TTM is $-1.051; its P/E ratio is -0.54; Spruce Biosciences is scheduled to report earnings on November 20, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.60M$ 2.00M$ 2.80M$ 3.07M$ 2.20M
Gross Profit$ 1.60M$ 2.00M$ 2.80M$ 3.10M$ 2.20M
EBIT$ -9.10M$ -11.53M$ -10.06M$ -12.47M$ -12.66M
EBITDA$ -9.09M$ -11.52M$ -10.06M$ -12.47M-
Net Income Common Stockholders$ -9.18M$ -11.63M$ -9.95M$ -12.35M$ -12.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 69.68M$ 81.15M$ 96.34M$ 108.03M$ 120.52M
Total Assets$ 75.52M$ 87.54M$ 103.95M$ 112.98M$ 125.96M
Total Debt$ 2.54M$ 3.89M$ 4.36M$ 3.73M$ 4.13M
Net Debt$ -67.14M$ -77.26M$ -91.98M$ -104.30M$ -116.39M
Total Liabilities$ 16.35M$ 20.91M$ 27.44M$ 27.60M$ 29.40M
Stockholders Equity$ 59.17M$ 66.62M$ 76.51M$ 85.38M$ 96.56M
Cash Flow-
Free Cash Flow$ -11.11M$ -14.96M$ -11.21M$ -12.28M-
Operating Cash Flow$ -11.11M$ -14.96M$ -11.21M$ -12.27M$ 1.99M
Investing Cash Flow--$ 9.30M$ 13.99M$ 22.00M
Financing Cash Flow$ -365.00K$ -227.00K$ -552.00K$ -405.00K$ -432.00K
Currency in USD

Spruce Biosciences Earnings and Revenue History

Spruce Biosciences Debt to Assets

Spruce Biosciences Cash Flow

Spruce Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis